FREE SHIPPING ACROSS EU FOR ORDERS OVER €199 FREE SHIPPING ACROSS EU FOR ORDERS OVER €199 FREE SHIPPING ACROSS EU FOR ORDERS OVER €199 FREE SHIPPING ACROSS EU FOR ORDERS OVER €199 FREE SHIPPING ACROSS EU FOR ORDERS OVER €199 FREE SHIPPING ACROSS EU FOR ORDERS OVER €199 FREE SHIPPING ACROSS EU FOR ORDERS OVER €199 FREE SHIPPING ACROSS EU FOR ORDERS OVER €199 FREE SHIPPING ACROSS EU FOR ORDERS OVER €199 FREE SHIPPING ACROSS EU FOR ORDERS OVER €199 FREE SHIPPING ACROSS EU FOR ORDERS OVER €199 FREE SHIPPING ACROSS EU FOR ORDERS OVER €199
Popular

Research Compound - Metabolic

Tirzepatide

Dual GLP-1/GIP Receptor Agonist

€80/unit 10mg, Lyophilised Powder

Tirzepatide is a synthetic dual agonist of the GLP-1 and GIP receptors used as a research tool in studies investigating incretin receptor signaling and related metabolic pathways.

View all compounds

For research and scientific purposes only. Not intended for human therapeutic use, diagnosis, treatment or consumption of any kind.

HPLC Verified >99% Purity Batch-by-batch independent testing. Certificate of Analysis included.
GMP Certified Facilities Manufactured under ISO 9001 & 13485 standards in South Korea.
<7 Day Delivery across Europe Controlled dispatch with tracking to any destination.
1,000+ Researchers Trust Us Active Telegram community of scientists and longevity researchers.

About Tirzepatide

Tirzepatide is a synthetic dual agonist of the GLP-1 and GIP receptors used as a research tool in studies investigating incretin receptor signaling and related metabolic pathways.

Mechanism of Action

Concurrent activation of the GLP-1 and GIP receptors produces a distinct signaling profile relative to single-receptor agonists, a mechanism under active investigation in incretin receptor pharmacology.

Research Applications

This material is intended solely for qualified laboratory research and analytical applications. It is not intended for human or veterinary use, clinical administration, diagnosis, treatment or prevention of any disease or condition.

  • GLP-1/GIP receptor signaling studies
  • In-vitro metabolic pathway research
  • Receptor pharmacology and assay development
  • Analytical and biochemical research

Reconstitution

5mg with 1ml, 10mg with 2ml, and 15mg with 3ml each yield an approximate concentration of 5mg/ml.

This vial contains 10 mg of peptide.

Open the full calculator for concentration & dilution presets →

Product Details

Compound Tirzepatide
Net Quantity 10mg, Lyophilised Powder
Physical Form Lyophilised Powder
Category Metabolic
Intended Use Laboratory research only
SKU TIRZEPATIDE-10MG

Shipping & Delivery

We ship across the European Union. Orders are processed within 1–2 business days and typically arrive within 3–5 business days to most EU destinations. All peptides are dispatched in secure packaging, with a tracking number sent once your order leaves our facility. Free shipping on orders over €199.

Explore Further

Peptide Calculator Work out reconstitution and aliquot volumes. Certificates of Analysis View HPLC purity results for every batch. Amino Acids Explorer The building blocks behind every peptide. Track Your Order Check dispatch and delivery status.

Related Compounds

Tirzepatide FAQs

Tirzepatide is a synthetic dual agonist of the GLP-1 and GIP receptors used as a research tool in studies investigating incretin receptor signaling and related metabolic pathways. It is supplied strictly for laboratory research and is not approved for human therapeutic use.

We ship across the European Union. Orders are processed within 1-2 business days and typically arrive within 3-5 business days to most EU destinations, dispatched in secure packaging.

Tirzepatide is supplied as 10mg, Lyophilised Powder. 5mg with 1ml, 10mg with 2ml, and 15mg with 3ml each yield an approximate concentration of 5mg/ml.

Yes. All GENIQ compounds are manufactured under GMP conditions in ISO 9001 and 13485 certified facilities, and independently verified by HPLC to greater than 99% purity on a batch-by-batch basis. Certificates of Analysis are available on request.